1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Plasma Protein Therapeutics Market
2.2. Global Plasma Protein Therapeutics Market, By Product, 2023 (US$ Million)
2.3. Global Plasma Protein Therapeutics Market, By Application, 2023 (US$ Million)
2.4. Global Plasma Protein Therapeutics Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Plasma Protein Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Plasma Protein Therapeutics Market Vendors
3.2. Strategies Adopted by Plasma Protein Therapeutics Market Vendors
3.3. Key Industry Strategies
4. Plasma Protein Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Plasma Protein Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Immunoglobulins
5.3.2. Albumin
5.3.3. Coagulation Factors
5.3.4. Alpha-1 Proteinase Inhibitor
5.3.5. Others (C1-esterase Inhibitors & Hyperimmune Globulins)
5.3.6. Pipeline Analysis
5.3.6.1. Phase III Drugs Analysis, Forecast till 2026
5.3.6.2. Phase II & Phase I (Tabular Representation)

6. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Hemophilia
6.3.2. Primary Immunodeficiency Disorder
6.3.3. Idiopathic Thrombocytopenic Purpura
6.3.4. Secondary Immunodeficiency
6.3.5. Others (Kawasaki Disease, Hereditary Angioedema, GBS, and CIDP)


7. North America Plasma Protein Therapeutics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
7.3. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.Plasma Protein Therapeutics Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
7.4.1.1.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
7.4.1.2.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
7.4.1.3.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)

8. UK and European Union Plasma Protein Therapeutics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
8.3. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.Plasma Protein Therapeutics Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.1.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.2.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.3.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.4.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.5.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.6.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)

9. Asia Pacific Plasma Protein Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
9.3. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.Plasma Protein Therapeutics Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.1.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.2.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.3.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.4.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.5.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.6.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)

10. Latin America Plasma Protein Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
10.3. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.Plasma Protein Therapeutics Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
10.4.1.1.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
10.4.1.2.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
10.4.1.3.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)

11. Middle East and Africa Plasma Protein Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
11.3. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.Plasma Protein Therapeutics Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
11.4.1.1.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
11.4.1.2.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2022-2032, USD (Million)
11.4.1.3.2. Plasma Protein Therapeutics Market: By Application, 2022-2032, USD (Million)

12. Company Profile
12.1. Baxter International
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Biotests
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. CSL Behring
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. GRIFOLS, S.A
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Kedrion
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Octapharma USA, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Shire Plc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. China Biologics
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Others
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives